Dec 18 (Reuters) - Hologic Inc HOLX.O:
FDA: HOLOGIC REMOVES BIOZORB 3D BIOABSORBABLE MARKERS DUE TO RISK FOR PATIENT COMPLICATIONS
FDA: THERE HAVE BEEN 252 REPORTED INJURIES RELATED TO HOLOGIC'S BIOZORB 3D BIOABSORBABLE MARKERS
FDA: IDENTIFIED HOLOGIC'S RECALL AS MOST SERIOUS TYPE; RECALL INVOLVES REMOVING DEVICES FROM WHERE THEY ARE USED/SOLD
Source text: [ID:]
Further company coverage: HOLX.O
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。